Friday 18 November 2011
FDA Revokes Approval of Avastin for Use as Breast Cancer Drug
SOUTH SAN FRANCISCO, Calif.----Genentech, a member of the Roche Group , announced today that the FDA Commissioner is revoking the approval of Avastin®Roche, through its Genentech division, currently controls the drug market for the disease with Lucentis and
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment